Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epithelial cell junctions are specialized protein complexes that provide structural integrity and regulate communication between adjacent epithelial cells (StatPearls, 2023). They consist of four primary types: tight junctions, adherens junctions, desmosomes, and gap junctions, which collectively maintain the epithelial barrier and regulate paracellular transport (Nature Reviews Molecular Cell Biology, 2014). These junctions are critical for maintaining cell polarity and tissue homeostasis, and their disruption is a key feature in various pathologies, including cancer metastasis and inflammatory diseases (Journal of Cell Science, 2017). In oncology, specific components like Claudin 18.2 are targeted by monoclonal antibodies such as Zolbetuximab to treat gastric and gastroesophageal cancers (The Lancet Oncology, 2021). Additionally, therapeutic agents like Larazotide aim to regulate tight junction permeability to treat autoimmune conditions such as celiac disease (American Journal of Gastroenterology, 2015). Understanding the molecular composition and regulation of these junctions is essential for developing strategies to enhance drug delivery or restore barrier function in chronic inflammatory states.
Modulation of paracellular permeability, Targeted cytotoxicity, Restoration of barrier function
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epithelial cell junction.